CUE
Cue Biopharma
$32.57
+$0.45 (+1.4%)Jul 27, 2026
Key metrics
The numbers that frame CUE today
- Market cap
- $131.77M
- P/E (TTM)
- -6.7
- EV / FCF
- -4.8
- Gross margin
- 100%
- EV / Sales
- 3.6
- ROIC
- -306%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $4.97
- 52wk High
- $45.50
Growth
Revenue and earnings trend for CUE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CUE
Is Cue Biopharma a good buy?
Hold. Cue Biopharma has excellent momentum, but weak quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Cue Biopharma is selling at a very high price.
What is the market capitalization of CUE?
Cue Biopharma's market capitalization is $131.77M.
What is the P/E ratio for CUE stock?
Cue Biopharma's current P/E ratio is -6.7.
What is the 52-week high for CUE stock?
The 52-week high for Cue Biopharma is $45.50. The current close of $32.57 is 28.4% below that high.
What is the 52-week low for CUE stock?
The 52-week low for Cue Biopharma is $4.97. The current close of $32.57 is 555.2% above that low.
Does CUE stock pay dividends?
Cue Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CUE?
Cue Biopharma's Debt / Equity ratio is 0.16.